Li Z - Search Results

1

Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC.

Kuang Y, Xu P, Wang J, Zheng Y, Sun X, Li Z, Gan R, Li H, Guo Y, Yao F, Zhu C, Ke Z, Tang K. Kuang Y, et al. Among authors: li z, li h. Mol Diagn Ther. 2021 Jul;25(4):487-494. doi: 10.1007/s40291-021-00532-8. Epub 2021 Jun 16. Mol Diagn Ther. 2021. PMID: 34133003 Free PMC article.

2

A rapid and durable response to cabozantinib in an osimertinib-resistant lung cancer patient with MET D1228N mutation: a case report.

Kuang Y, Wang J, Xu P, Zheng Y, Bai L, Sun X, Li Z, Gan R, Li H, Ke Z, Tang K. Kuang Y, et al. Among authors: li z, li h. Ann Transl Med. 2021 Aug;9(16):1354. doi: 10.21037/atm-21-3861. Ann Transl Med. 2021. PMID: 34532491 Free PMC article.

3

Gut-derived fungemia due to Kodamaea ohmeri combined with invasive pulmonary aspergillosis: a case report.

Li ZM, Kuang YK, Zheng YF, Xu PH, Wang JY, Gan RJ, Li HX, Bai LH, Xie CM, Tang KJ. Li ZM, et al. BMC Infect Dis. 2022 Dec 3;22(1):903. doi: 10.1186/s12879-022-07866-6. BMC Infect Dis. 2022. PMID: 36460998 Free PMC article.

4

Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study.

Li H, Zheng Y, Xu P, Li Z, Kuang Y, Feng X, He J, Li J, Chen X, Bai L, Tang KJ. Li H, et al. Among authors: li z, li j. Front Pharmacol. 2023 Apr 13;14:1142016. doi: 10.3389/fphar.2023.1142016. eCollection 2023. Front Pharmacol. 2023. PMID: 37124234 Free PMC article.

5

An "AND" logic gate-based supramolecular therapeutic nanoplatform for combatting drug-resistant non-small cell lung cancer.

Huang Q, Ding C, Wang W, Yang L, Wu Y, Zeng W, Li Z, Shi Z, Mei L, Zeng X, Zhao Y, Chen H. Huang Q, et al. Among authors: li z. Sci Adv. 2024 Sep 27;10(39):eadp9071. doi: 10.1126/sciadv.adp9071. Epub 2024 Sep 25. Sci Adv. 2024. PMID: 39321294 Free PMC article.

6

Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy.

Huang P, Yang Y, Wang W, Li Z, Gao N, Chen H, Zeng X. Huang P, et al. Among authors: li z. Biomaterials. 2023 Aug;299:122157. doi: 10.1016/j.biomaterials.2023.122157. Epub 2023 May 9. Biomaterials. 2023. PMID: 37196407

7

Charge-reversal nanomedicine based on black phosphorus for the development of A Novel photothermal therapy of oral cancer.

Li Z, Liu Q, Zhang Y, Yang Y, Zhou X, Peng W, Liang Z, Zeng X, Wang Q, Gao N. Li Z, et al. Drug Deliv. 2021 Dec;28(1):700-708. doi: 10.1080/10717544.2021.1909176. Drug Deliv. 2021. PMID: 33818230 Free PMC article.

8

Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy.

Li Z, Yang Y, Wei H, Shan X, Wang X, Ou M, Liu Q, Gao N, Chen H, Mei L, Zeng X. Li Z, et al. J Control Release. 2021 Oct 10;338:719-730. doi: 10.1016/j.jconrel.2021.09.005. Epub 2021 Sep 10. J Control Release. 2021. PMID: 34509586

9

Polydopamine surface-modified hyperbranched polymeric nanoparticles for synergistic chemo/photothermal therapy of oral cancer.

Yin X, Li Z, Zhang Y, Zeng X, Wang Q, Liang Z. Yin X, et al. Among authors: li z. Front Bioeng Biotechnol. 2023 May 5;11:1174014. doi: 10.3389/fbioe.2023.1174014. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37214280 Free PMC article.

10

Architecturally designed sequential-release hydrogels.

Zhang D, Li Z, Yang L, Ma H, Chen H, Zeng X. Zhang D, et al. Among authors: li z. Biomaterials. 2023 Dec;303:122388. doi: 10.1016/j.biomaterials.2023.122388. Epub 2023 Nov 9. Biomaterials. 2023. PMID: 37980822 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113,237 results

Search Page

Filters